What Is AML? The Shock of Diagnosis
Quick Answers: The Shock of an AML Diagnosis
Release Date: 05/01/2021
What Should Myeloma Patients Know About Palliative Care?
Quick Answers: The Shock of an AML Diagnosis
As a patient with or a care partner, you may have heard of palliative care. But what exactly is it? In the final segment of our four-part Quick Answers for Myeloma Patients podcast series, Joshua Richter, MD, associate professor of medicine at the Tisch Cancer Institute, Mount Sinai School of Medicine, breaks down the common misconceptions about palliative care and explains how patients can benefit from better understanding and embracing it.
info_outline
Who Should Consider a Stem Cell Transplant for Multiple Myeloma?
Quick Answers: The Shock of an AML Diagnosis
How do you know when it is time to consider a stem cell transplant as a treatment for ? How does an expert weigh the pros and cons of this intense procedure? In part three of this four-part series, Joshua Richter, MD, associate professor of medicine at the Tisch Cancer Institute, Mount Sinai School of Medicine, talks to Patient Power writer Youssef Rddad about what factors play into decision-making for stem cell transplants.
info_outline
Doctor Explains the Symptoms of Multiple Myeloma Relapse
Quick Answers: The Shock of an AML Diagnosis
There’s a reason myeloma patients and doctors talk about the “remission/relapse cycle.” In the second installment of our four-part podcast series, Joshua Richter, MD, associate professor of medicine at the Tisch Cancer Institute, Mount Sinai School of Medicine, talks to Patient Power writer Youssef Rddad about the initial symptoms of relapse and the remission/relapse cycle. Dr. Richter also discusses potential treatments for patients who have relapsed.
info_outline
How Will My Newly Diagnosed Myeloma Be Treated?
Quick Answers: The Shock of an AML Diagnosis
One of the first questions that pops into each patient and caregiver’s mind after a diagnosis is: “How will we treat this?” In part one of this four-part podcast series, Joshua Richter, MD, associate professor of medicine at the Tisch Cancer Institute, Mount Sinai School of Medicine, talks to Patient Power writer Youssef Rddad about first-line treatment options for newly diagnosed patients. Dr. Richter explains how often a patient may need to receive treatment and how they can expect to feel during the process.
info_outline
What Are Reasonable Expectations for My Future?
Quick Answers: The Shock of an AML Diagnosis
In the ninth episode of a nine-part podcast series, Dr. Thomas LeBlanc, MD, Leukemia Specialist and Patient Experience Researcher at Duke University School of Medicine, emphasizes the importance of focusing on the goal that's right in front of you: remission. For some AML patients remission and a cure are likely outcomes; for others, disease control and a focus on prolonging and maintaining the quality of life is the path forward.
info_outline
What Financial Support Options Exist for AML Patients?
Quick Answers: The Shock of an AML Diagnosis
In the eighth episode of a nine-part podcast series, Dr. Thomas LeBlanc, MD, Leukemia Specialist and Patient Experience Researcher at Duke University School of Medicine, discusses the resources available to help AML patients navigate what can be a very complicated financial process. There is often a support person who specializes in patient financial services, and there are several programs to help offset out-of-pocket costs for medications and treatments.
info_outline
How is Life Going to Change?
Quick Answers: The Shock of an AML Diagnosis
In the seventh episode of a nine-part podcast series, Dr. Thomas LeBlanc, MD, Leukemia Specialist and Patient Experience Researcher at Duke University School of Medicine, highlights "that there will be many unexpected, unpredictable things, and you have to sort of roll with it." When first diagnosed, an AML patient often loses significant control over how they spend their time, which can affect their work, hobbies and social life.
info_outline
How Can I Access Support During Treatment?
Quick Answers: The Shock of an AML Diagnosis
In the sixth episode of a nine-part podcast series, Dr. Daniel Pollyea, MD, Clinical Director of Leukemia Services at the University of Colorado, discusses the importance of a support team during acute myeloid leukemia (AML) treatment. It is important to reach out to your medical team with any concerns you have, and it is equally important to communicate with your friends, family and loved ones to access help when it is needed.
info_outline
What Can I Expect During Treatment?
Quick Answers: The Shock of an AML Diagnosis
In the fifth episode of a nine-part podcast series, Dr. Daniel Pollyea, MD, Clinical Director of Leukemia Services at the University of Colorado, discusses beginning acute myeloid leukemia treatment and how important it is for AML patients and care partners to be educated on the time commitment, decision-making process, and possible treatment side effects that accompany AML therapy.
info_outline
What Are the Treatment Options for AML?
Quick Answers: The Shock of an AML Diagnosis
In the fourth episode of a nine-part podcast series, Dr. Eunice Wang, MD, Chief of Leukemia at Roswell Park Comprehensive Cancer Center, guides newly diagnosed acute myeloid leukemia patients through the different AML treatment options that are available to them. Dr. Wang explains how a patient's age, fitness, AML subtype, finances and personal preferences can inform the treatment decision.
info_outlineIn this first episode of a nine-part podcast series, Eunice Wang, MD, Chief of Leukemia at Roswell Park Comprehensive Cancer Center, offers a thorough explanation of what it means to be diagnosed with acute myeloid leukemia (AML). Dr. Wang clarifies what is happening in your body, why there are no "stages" with blood cancers, and why an AML patient and their care partner should be hopeful, despite the shock of the diagnosis.